Abstract 11812: Heterogeneity in Treatment Benefits of Oral Semaglutide in People with Heart Failure with Preserved Ejection Fraction
Importance: Heart failure with preserved ejection fraction (HFpEF) is common among people with visceral adiposity and type 2 diabetes, yet evidence regarding the benefits of oral formulations of semaglutide in clinical practice and the patients most likely to benefit remains limited. Objective: To evaluate the...